Providence Health & Services
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1859-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.providence.org
Effect and Utilization of Protected Time Among Interns on Extended Duty-Hour Call Shifts
Not Applicable
Terminated
- Conditions
- FatigueSleep DeprivationDepression
- Interventions
- Behavioral: Protected time and Dedicated time
- First Posted Date
- 2009-09-23
- Last Posted Date
- 2019-09-26
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 11
- Registration Number
- NCT00983008
- Locations
- 🇺🇸
Providence St. Vincent Medical Center, Portland, Oregon, United States
Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC)
Phase 2
Terminated
- Conditions
- Melanoma
- Interventions
- Biological: PBMC re-infusionBiological: CD25 depletion
- First Posted Date
- 2009-08-19
- Last Posted Date
- 2018-08-28
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 5
- Registration Number
- NCT00961376
- Locations
- 🇺🇸
Providence Portland Medical Center, Portland, Oregon, United States
A Trial of Single Port Laparoscopic Cholecystectomy Versus Four Port Laparoscopic Cholecystectomy
Phase 3
Completed
- Conditions
- Cholecystectomy, Laparoscopic
- Interventions
- Device: Laparoscopic cholecystectomy surgery
- First Posted Date
- 2009-05-05
- Last Posted Date
- 2011-05-18
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 50
- Registration Number
- NCT00892879
- Locations
- 🇺🇸
Providence Portland Medical Center, Portland, Oregon, United States
Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- Non Small Cell Lung Cancer
- First Posted Date
- 2009-02-25
- Last Posted Date
- 2016-09-27
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 6
- Registration Number
- NCT00850785
- Locations
- 🇺🇸
Providence Portland Medical Center, Portland, Oregon, United States
Retrospective Study of the Impact of Drug Eluting Stents
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2007-06-18
- Last Posted Date
- 2007-08-02
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 9800
- Registration Number
- NCT00487604
- Locations
- 🇺🇸
Sacred Heart Medical Center, Spokane, Washington, United States
Angiotensin II Antagonism of TGF-Beta 1
Not Applicable
Completed
- Conditions
- HypertensionDiabetic Nephropathy
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2007-08-02
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 36
- Registration Number
- NCT00320970
- Locations
- 🇺🇸
Providence Medical Research Center, Spokane, Washington, United States
Carotid Artery Stenting With Protection Registry
Phase 3
Completed
- Conditions
- Carotid Artery Stenosis
- Interventions
- Device: Carotid Stent with Distal Protection Device
- First Posted Date
- 2006-04-27
- Last Posted Date
- 2010-08-26
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 62
- Registration Number
- NCT00318851
- Locations
- 🇺🇸
Sacred Heart Medical Center, Spokane, Washington, United States
Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
Not Applicable
Completed
- Conditions
- Transplant Bone Disease
- Interventions
- First Posted Date
- 2006-03-14
- Last Posted Date
- 2018-08-29
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 43
- Registration Number
- NCT00302627
- Locations
- 🇺🇸
Providence Medical Research Center, Spokane, Washington, United States
The Heart Institute of Spokane Diet Study
Phase 3
Completed
- Conditions
- Myocardial Infarction
- Interventions
- Behavioral: Mediterranean dietBehavioral: American Heart Association Step 2 diet
- First Posted Date
- 2005-12-23
- Last Posted Date
- 2010-08-24
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 202
- Registration Number
- NCT00269425
- Locations
- 🇺🇸
Providence Medical Research Center, Spokane, Washington, United States
Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer
Phase 2
Terminated
- Conditions
- Non-small-Cell Lung Carcinoma
- First Posted Date
- 2005-10-04
- Last Posted Date
- 2011-05-18
- Lead Sponsor
- Providence Health & Services
- Target Recruit Count
- 40
- Registration Number
- NCT00232206
- Locations
- 🇺🇸
Providence Portland Medical Center, Portland, Oregon, United States
© Copyright 2025. All Rights Reserved by MedPath